Viopas Venture Consulting GmbH |

Viopas Venture Consulting GmbH

Viopas Venture Consulting was founded by a team of industry professionals combining the expertise of serial entrepreneurs, venture capital fund managers and senior C-level Bio-Pharma executives. All team members contribute their substantial industry track record of managing and investing in life science companies, developing pharmaceutical products, assessing medical devices, diagnostics, services and research tools, and providing financial expertise. The team has extensive expertise in development of pharmaceutical products for a wide range of diseases, such as immunology, oncology, ophthalmology, neurology, neuromuscular conditions and rare diseases. As entrepreneurs we share our knowledge with the next generation of inspiring and talented leaders to produce innovative healthcare solutions for the benefit of patients.

About Viopas Venture Consulting GmbH:

Ownership Structure	Viopas Venture Consulting is controlled by its Managing Partners. The company is headquartered in Switzerland with a fully-owned subsidiary in Germany and a presence in Vienna/Austria
Managing Partners	Switzerland: Simon Nebel, PhD, MBA, (Founder), longstanding track record as a venture capital investor, invested in and managed more than 20 life science companies, Chairman of the BoD of Marinomed AG Thomas Meier, PhD, dynamic life-science entrepreneur and internationally recognized neuroscientist with excellent track record in clinical research of orphan diseases. Executive CEO and CSO positions, Partner at Board Advisors Deutschland AG Ulf Grawunder, PhD, serial entrepreneur with strong track record in company building and exits (ex-CEO and founder of 4-Antibody AG and NBE Therapeutics AG). Co-founder/CEO of T-CURX GmbH, Vice President of Swiss Biotech Association Daniel Pajer, Swiss CPA, EMBA, former Equity Partner at PwC, long standing leadership and corporate finance experience in Switzerland and overseas. Expert in financial modelling/reporting, and business planning. Board of Directors of Raiffeisenbank Basel. Germany: Thomas Loeser, 20+ year track record as CFO of several German, Swiss and US biotech companies with particular focus on transatlantic growth/fi- nancing strategies, US capital markets and M&A/exits. Member of Harvard Alumni Association
Areas of Business/Services	Comprehensive development expertise in oncology, immunology, ophthalmology, rare diseases, neurology and neuromuscular diseases Complimentary team expertise in CMC/drug development, digital health, corporate finance/governance, licensing and M&A. Strategic counsel to investors interested in the healthcare sector, including family offices, high-net worth individuals, and institutional investors.

Contact:

Simon Nebel, PhD, MBA, Founder, Managing Partner, CEO

Addresses	Thiersteinerallee 17, CH-4053 Basel Neuwiesenstrasse 8, 8610 Uster Am Klopferspitz 19, D-82152 Martinsried
Telephone	+49 173 565 26 97
E-Mail	info@viopasventure.ch
Web Address	www.viopasventure.ch
Social Media	LinkedIn
Date of Incorporation/Number of Employees	2016/10
Other	Company references: Marinomed AG, DyCare, Santhera AG, Peak Spirit GmbH

ARTIKEL ZU DIESEN SCHLAGWORTEN